Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel is supported with funding from Agios (Gold).

The Sickle Cell Disease Channel is supported with funding from Agios (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

EHA 2019 | SCD: incentive spirometry

Bart Biemond • 14 Jun 2019
EHA 2019
Non-Malignant Sickle Cell Disease

Bart Biemond, MD, PhD, Academic Medical Centre, Amsterdam, Netherlands, discusses incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Bart Biemond

SCD: Assessing bleeding severity in thrombocytopenic patients
1:39
SCD: Assessing bleeding severity in thrombocytopenic patients
Bart Biemond • 15 Jun 2019
Vaso-occlusion, multi-cell adhesion & the HOPE study
3:29
Vaso-occlusion, multi-cell adhesion & the HOPE study
Bart Biemond • 15 Jun 2019
Novel agents for sickle cell disease
1:53
Novel agents for sickle cell disease
Bart Biemond • 16 Jul 2018
An update on sickle cell disease treatment
2:42
An update on sickle cell disease treatment
Bart Biemond • 16 Apr 2018

Related Videos

Safety and efficacy of etavopivat in adolescents with SCD: the ongoing HIBISCUS Kids trial
3:10
Safety and efficacy of etavopivat in adolescents with SCD: the ongoing HIBISCUS Kids trial
Bart Biemond • 8 Dec 2025
A case report used to evaluate gene therapy outcomes in transfusion-dependent β-thalassemia
1:54
A case report used to evaluate gene therapy outcomes in transfusion-dependent β-thalassemia
Bart Biemond • 2 Dec 2025
Exciting and potentially practice-changing hemophilia updates from ASH 2025
1:59
Exciting and potentially practice-changing hemophilia updates from ASH 2025
Bart Biemond • 12 Dec 2025
Plasma-derived VWF/FVIII prophylaxis in children under 6 with VWD: first results from WIL-33
2:51
Plasma-derived VWF/FVIII prophylaxis in children under 6 with VWD: first results from WIL-33
Bart Biemond • 8 Dec 2025
The content of VJHemOnc is intended for healthcare professionals